Colgate-Palmolive Company (CL) has been performing impressively as evidenced by an anticipated 31% undervaluation and a considerable 40% rise in stock. This ascent has been attributed to stock surpassing revenue forecasts, quarterly earnings beating expectations, and strong Q1 2024 performance. Furthermore, the company has experienced an increase in institutional owner dominance at 84%. Notably,
Lighthouse Investment Partners LLC and Bank of Montreal Can have both purchased considerable amounts of shares. Other positive highlights include a regular quarterly dividend declaration, Alpha DNA Investment Management LLC's acquisition of 23,939 shares, and a bullish stance from Piper Sandler with a target of $121. Despite
Wells Fargo's surprising downgrade, the company's prospects remain unperturbed. Additionally, the stock has outperformed many of its competitors, exhibiting robust momentum. The company's earnings have been positively impacted by higher prices, further boosted by strong demand leading to raised 2024 forecasts.
Its stable returns on capital and consistent dividend growth render it an attractive long-term investment.
Colgate-Palmolive Company CL News Analytics from Fri, 26 Jan 2024 08:00:00 GMT to Sat, 28 Sep 2024 09:59:47 GMT -
Rating 8
- Innovation 6
- Information 9
- Rumor -4
